Category: Hansen Medical Inc.
Robot surgery systems maker Hansen Medical's Q1 revenues slide and losses widen, sending Wall Street away in droves.
California medical device maker Hansen Medical (NSDQ:HNSN) posted a tough 1st quarter, sending shares down 11% in afternoon trading yesterday.
The robotic surgery devices maker posted $17.2 million in losses, or 26¢ per share, on $3 million in sales during the 3 months ended March 31, 2013.
The FDA approves Johnson & Johnson's 1st-of-a-kind Invokana diabetes drug, designed to flush unabsorbed sugar from the bloodstream.
The FDA approved a 1st-of-its-kind treatment for Type 2 diabetes, Johnson & Johnson's (NYSE:JNJ) Invokana, with the federal watchdog agency citing it as a pioneer in a new class of diabetes drug.
Shares of robotic surgery device makers, Intuitive Surgical, Mako Surgical and Hansen Medical all slid today on Wall Street after the Massachusetts Board of Registration in Medicine issues a warning on the risk of adverse events during the procedures.
Shares of the leading robotic surgery device makers all fell today, after a Massachusetts medical board issued an advisory to surgeons warning of possible risks with the cutting-edge technology.
Shares of Hansen Medical are down after the medical device company reported wider 2012 losses and declines to issue guidance for 2013.
Hansen Medical (NSDQ:HNSN) managed to eke out a profit during the 4th quarter on the sale and licensing of some of its patents, but still posted wider losses for 2012, sending shares down YY% on Wall Street last week.
